Akeso To Boost Manufacturing Of Cancer Drug

Akeso CFO Bing Wang says the Chinese biotech firm is investing “significantly” to expand manufacturing of its lung cancer drug as it anticipates growing demand in China and the US. He speaks exclusively to Bloomberg after Akeso presented positive results for the drug at the American Society of Clinical Oncology’s annual meeting. (Source: Bloomberg)